Team

The people behind BioGntx.

01. Our story

Building an encapsulation platform since 2021.

Since 2021, BioGntx has focused on developing its proprietary lipid-delivery technology, building R&D-scale prototypes and evaluating the platform through selected formulation and partner-oriented projects.

Today, BioGntx works with ingredient companies, brands and development partners to explore formulation feasibility, develop R&D-scale prototypes and evaluate potential pathways for further development.

BioGntx: science meets craft

Together

Science, commercial focus and craft, in one place.

02. The team

One focused team.

A focused team bringing together science, formulation development, commercial strategy and operations to evaluate new opportunities and build meaningful technical partnerships.

The team

10 people

  • Diggy ter Horst

    CEO

    Diggy ter Horst

    Diggy has served as a Founder and CEO in various revolutionary (tech) companies worldwide and has a proven track nurturing young companies into successful businesses.

  • Anniken Amdam

    Commercial Director

    Anniken Amdam

    Anniken is a seasoned business leader with extensive experience in entrepreneurship, company development and strategic growth. Throughout her career, she has specialised in driving executive leadership and building high-performing organisations.

  • Rob Beens

    CCO

    Rob Beens

    Rob provides Strategy & Management support to BioGntX, with a base in The Netherlands. Over the last 35 years Rob has been active as executive director/CEO in different companies and industries.

  • Raissa Davis

    Technology Transfer Manager

    Raissa Davis

    Raissa is a Project Manager and Technology Transfer specialist with over 10 years of experience in the biotech and pharma industry. At BioGntx, she helps translate the company's NLC technology and formulation know-how into structured partner projects. She connects commercial, R&D, regulatory, and IP stakeholders, making sure collaborations move from early discussion to clear integration plans, prototype development, and follow-up.

  • Richard van Bueren

    CFO

    Richard van Bueren

    Richard serves as Chief Financial Officer, bringing over two decades of experience in financial management, corporate governance and international business operations. His expertise spans financial strategy, reporting, risk management and funding for high-growth and innovation-driven companies.

  • Joy van Leeuwen

    Marketing Communication Manager

    Joy van Leeuwen

    Joy van Leeuwen is a results-driven Marketing Communication Manager with a strong focus on brand growth, strategic storytelling and digital engagement. She translates business goals into impactful campaigns that connect with target audiences effectively.

  • Rinus Beintema

    CIO

    Rinus Beintema

    Rinus is the founder and owner of Medican Campus B.V. He brings a unique combination of entrepreneurial leadership, scientific expertise and hands-on experience in laboratory environments.

  • Vanessa Häusler

    Operations & Management Support

    Vanessa Häusler

    Vanessa supports the BioGntx team with administrative coordination, project organisation and day-to-day operations. With experience in office management and HR support, she ensures smooth processes and effective communication across all areas of the company.

  • George Joubert

    R&D Scientist & Co-inventor

    George Joubert

    George is an R&D Scientist and Co-inventor at BioGntx with a Bachelor's degree in Pharmacology from the University of Portsmouth. He supports formulation research through precise laboratory work, prototype development, data analysis and a strong focus on quality.

  • Margrit Fares Mikhaeil

    Quality & Regulatory Consultant

    Margrit Fares Mikhaeil

    Margrit is a Quality & Regulatory Consultant with over 15 years of international experience in the pharmaceutical, biotechnology and nutraceutical industries. She specialises in quality management systems, regulatory compliance and operational readiness, helping innovative companies translate R&D into commercially ready operations.

Partner with BioGntx.

Have a difficult-to-formulate lipophilic active? Let's explore whether a feasibility project, prototype-development program or technical collaboration could be the right next step.

Start a feasibility discussion